When the CDC chose to lift restrictions on the vaccinated, ICAN went to work. Through its attorneys, it formally demanded that the CDC also (at the least) lift restrictions on the naturally immune. It provided the CDC with over 60 studies reflecting that natural immunity is more durable and robust than vaccine immunity. The CDC’s response is shameful.
Emails Show NIH Dismissed Potential Vaccine Risk and Focused on Vaccine Development Instead of Early Treatment Options - ICAN - Informed Consent Action Network
ICAN has received emails showing that very early in the pandemic the National Institute of Allergy and Infectious Diseases (NIAID) shirked monoclonal antibody treatment in favor of vaccines and played down concerns about vaccine enhanced illness.
Surgisphere: governments and WHO changed Covid-19 policy based on suspect data from tiny US company
Surgisphere, whose employees appear to include a sci-fi writer and adult content model, provided database behind Lancet and New England Journal of Medicine hydroxychloroquine studies
Judicial Watch: Former NIH Director Francis Collins Emails Reveal British Physicians and Scientists Group Recommended Ivermectin for Preventions and Treatment of COVID-19 - Judicial Watch
(Washington, D.C.) Judicial Watch announced today that it received 254 pages of records from the Department of Health and Human Services (HHS) this included emails of then-Director of the National Institutes of Health (NIH) Francis Collins regarding a British group’s recommendations on the use of Ivermectin to prevent and treat COVID-19.
Denial of Early Covid-19 Treatment – A Crime Against Humanity
American citizens were recently coerced into being part of the test or control groups of a medical experiment, without adequate knowledge and without their consent. Hundreds of thousands of Americans likely died from the resulting denial of timely and adequate treatment of Covid-19 and more importantly, its preventable secondary conditions. This was an egregious violation of The Nuremberg Code on human rights. The time has come for jurisprudence and restitution to those harmed.
EARLY VIRAL CLEARANCE AMONG COVID-19 PATIENTS WHEN GARGLING WITH POVIDONE-IODINE AND ESSENTIAL OILS – A CLINICAL TRIAL
Background Gargling had been reported to have significant roles in the prevention and treatment of respiratory tract infections. The purpose of this study was to assess the ability of regular gargling to eliminate SARS-CoV-2 in the oropharynx and nasopharynx. Methodology This pilot, open labeled, randomized, parallel study compared the effect of 30 seconds, 3 times/day gargling using 1% povidone-iodine (PVP-I), essential oils and tap water on SARS-CoV-2 viral clearance among COVID-19 patients in a tertiary hospital in Kuala Lumpur. Progress was monitored by day 4,6 and 12 PCR (Ct value), gargling and symptoms diary as well as clinical observations. Results Five confirmed Stage 1 COVID-19 patients were recruited for each arm. The age range was from 22 to 56 years old. The majority were males. Two respondents had co-morbidities, which were asthma and obesity. Viral clearance was achieved at day 6 in 100%, 80%, 20% and 0% for 1% PVP-I, essential oils, tap water and control group respectively. Analysis of 1% PVP-I group versus control group showed significant p-value for comparison of PCR results on Day 4, Day 6 and Day 12. Conclusions This preliminary study showed that gargling with 1% PVP-I and essential oils show great potential to be part of the treatment and management of Stage 1 COVID-19. Larger studies are required to ascertain the benefit of gargling for different stages of COVID-19 patients. This study was registered in clinicaltrial.gov ([NCT04410159][1]). ### Competing Interest Statement The authors have declared no competing interest. ### Clinical Trial clinicaltrial.gov ([NCT04410159][1]) ### Clinical Protocols ### Funding Statement None ### Author Declarations I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained. Yes The details of the IRB/oversight body that provided approval or exemption for the research described are given below: This study received approval from the Research and Ethics Committee, Faculty of Medicine, Universiti Kebangsaan Malaysia (UKM PPI/111/8/JEP-2020-372). All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived. Yes I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance). Yes I have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable. Yes Data is available upon request [1]: /lookup/external-ref?link_type=CLINTRIALGOV&access_num=NCT04410159&atom=%2Fmedrxiv%2Fearly%2F2020%2F09%2F09%2F2020.09.07.20180448.atom
Povidone Iodine to Reduce Viral Load in Patients With COVID-19
This randomized clinical trial investigates the efficacy of nasopharyngeal povidone iodine solutions in reducing the viral load of patients with COVID-19.
Virucidal effect of povidone iodine on COVID-19 in the nasopharynx: an open-label randomized clinical trial - PubMed
Povidone-iodine (PVP-I) is a time-tested antiseptic agent with excellent virucidal (99.99%) properties. Repurposing it against coronavirus disease-19 (COVID-19) is a relatively newer concept and has been sparsely tested in vivo. The most common route of entry of severe acute respiratory syndrome cor …
Chloroquine is a potent inhibitor of SARS coronavirus infection and spread
Severe acute respiratory syndrome (SARS) is caused by a newly discovered coronavirus (SARS-CoV). No effective prophylactic or post-exposure therapy is currently available.We report, however, that chloroquine has strong antiviral effects on SARS-CoV infection ...
War on Ivermectin: The Medicine That Saved Millions and Could Have Ended the Pandemic
Buy War on Ivermectin: The Medicine That Saved Millions and Could Have Ended the Pandemic by Kory, Pierre, McCarthy, Jenna, Bigtree, del (ISBN: 9781510773868) from Amazon's Book Store. Everyday low prices and free delivery on eligible orders.
The Timeline of Major Battles In the Global War on Ivermectin - Part 3
The final phases of the Disinformation war on ivermectin kicks into high gear with the launch of the "Horse Dewormer" public relations campaign followed by the publication of Pharma corrupted trials.
The Timeline of Major Battles In the Global War on Ivermectin - Part 2
In the wake of the FLCCC press conference, Senate Testimony and review paper retraction, suddenly Merck fires the first public salvo in the Disinformation war by posting brazen lies on their website.
A Timeline of Major Battles In the Global War on Ivermectin - Part 1
My chronology of the Disinformation tactics deployed to paint ivermectin as an ineffective horse dewormer against Covid. Largely taken from the ever-evolving keynote lecture I give at conferences
A Letter to Dr Andrew Hill | Dr Tess Lawrie | Oracle Films
In October 2020 Dr Andrew Hill was tasked to report to the World Health Organisation on the dozens of new studies from around the world suggesting that Ivermectin could be a remarkably safe and effect
Negative effectiveness & natural immunity in the MSM, and another expert comes round?
It was only a few days ago that we added to our ongoing reporting on COVID-19 vaccine negative effectiveness (the notion that the jabs make COVID-19 infection, and even death, more likely), and now we can add to that some more evidence and a source from the mainstream news.
Natural immunity conspiracy theory now obvious fact
As evidence continues to pour in, the COVID-19 skeptics continue to be proven right. NBC News has reported on a new study published in the Lancet, commenting: “The immunity generated from an infection was found to be “at least as high, if not higher” than that provided by two doses of an mRNA vaccine.” They also acknowledged that “the immunity acquired from infection did appear to wane more slowly than the immunity from two doses of an mRNA vaccine”.